» Articles » PMID: 2936369

Cerebral Photosensitisation by Haematoporphyrin Derivative. Evidence for an Endothelial Site of Action

Overview
Journal Br J Cancer
Specialty Oncology
Date 1986 Jan 1
PMID 2936369
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Exposure of the cranium to white light in mice that had been given haematoporphyrin derivative (HpD) led to a rapid onset of vasogenic cerebral oedema, cerebral necrosis, coma and death. Selectivity of the initial damage for endothelium was suggested by (a) early breakdown (less than 1 h) of the blood-brain barrier (BBB) as shown by increased permeability to Evans blue (b) separation and increased vesiculation of endothelial cells at 2 h and (c) endothelial cell pyknosis at 3--4 h in small vessels next to apparently undamaged neurones and neuroglia. There was no damage to myelin sheaths, and astrocytes showed only end-feet oedema, a reaction to exudation of protein-rich fluid. Within a few hours of illumination, most cells in the illuminated area were necrotic. Cerebral photosensitivity persisted for at least 12 weeks after a single injection of HpD. Our results suggest that the primary site of damage in the brain is the endothelium of small vessels, and that HpD remains associated with this for a remarkably long time. These findings are relevant to the mechanisms by which photodynamic therapy damages other tissues, including neoplasms, and particularly to the possible application of this treatment to brain tumours.

Citing Articles

The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.

Lilge L, Olivo M, SCHATZ S, Maguire J, Patterson M, Wilson B Br J Cancer. 1996; 73(3):332-43.

PMID: 8562339 PMC: 2074425. DOI: 10.1038/bjc.1996.58.


Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.

Grant W, Speight P, MacRobert A, Hopper C, Bown S Br J Cancer. 1994; 70(1):72-8.

PMID: 8018544 PMC: 2033305. DOI: 10.1038/bjc.1994.252.


Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.

Barr H, Tralau C, MacRobert A, Krasner N, Boulos P, Clark C Br J Cancer. 1987; 56(2):111-8.

PMID: 3663462 PMC: 2002142. DOI: 10.1038/bjc.1987.166.


Selective necrosis of malignant gliomas in mice using photodynamic therapy.

Sandeman D, Bradford R, Buxton P, Bown S, Thomas D Br J Cancer. 1987; 55(6):647-9.

PMID: 3620307 PMC: 2002045. DOI: 10.1038/bjc.1987.131.


Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model.

White L, Gomer C, Doiron D, Szirth B Br J Cancer. 1988; 57(5):455-8.

PMID: 3395551 PMC: 2246389. DOI: 10.1038/bjc.1988.106.


References
1.
BERENBAUM M, BONNETT R, Scourides P . In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer. 1982; 45(4):571-81. PMC: 2010978. DOI: 10.1038/bjc.1982.94. View

2.
Laws Jr E, Cortese D, Kinsey J, Eagan R, Anderson R . Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study. Neurosurgery. 1981; 9(6):672-8. DOI: 10.1227/00006123-198112000-00010. View

3.
Lieberman A, Foo S, Ransohoff J, Wise A, George A, Gordon W . Long term survival among patients with malignant brain tumors. Neurosurgery. 1982; 10(4):450-3. DOI: 10.1227/00006123-198204000-00006. View

4.
ROUNDS D, Jacques S, SHELDEN C, Shaller C, OLSON R . Development of a protocol for photoradiation therapy of malignant brain tumors: part 1. Photosensitization of normal brain tissue with hematoporphyrin derivative. Neurosurgery. 1982; 11(4):500-5. View

5.
Denekamp J, Hill S, Hobson B . Vascular occlusion and tumour cell death. Eur J Cancer Clin Oncol. 1983; 19(2):271-5. DOI: 10.1016/0277-5379(83)90426-1. View